News
1d
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss: Study
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...
4d
MedPage Today on MSNMenopause Hormone Therapy Users May Lose More on Weight Loss InjectableAmong 120 women with overweight or obesity, MHT users lost 19.18% of their total body weight with tirzepatide (Mounjaro, ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.
A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results